Quick take: Today’s strongest signals concern institutions learning to distinguish evidence from assertion: a newborn-care warning emerges from a million records, a court preserves citizen-led fraud cases, and power planners begin testing whether data-centre demand is real.
Newborn vitamin K non-receipt rises sharply in US hospital data
An analysis released on 1 September found that the share of US newborns without a documented vitamin K injection within a day of birth rose from 5.2% in January to 8.1% in June 2026. The Truveta study covered 1,026,375 infants and makes a worrying change visible sooner than conventional national surveillance might. Vitamin K enables clotting; newborns begin with low reserves, and the CDC says babies who miss the injection are 81 times more likely to develop late vitamin K deficiency bleeding, which can affect the brain or gut. The limitation is important: electronic records show non-receipt, not necessarily a parent’s reason, and the analysis does not yet establish a corresponding rise in bleeding cases. Even so, the scale and acceleration justify attention. Some paediatric practices are now stocking the injection so families can reconsider after leaving hospital. Expectant parents can ask their maternity team before delivery what the shot prevents, when it is given and which sources support any concern they encounter online. Context: Reuters.
US appeals court preserves citizen-led fraud enforcement
On 1 September, the 11th US Circuit Court of Appeals unanimously rejected a constitutional challenge to the False Claims Act mechanism that lets private whistleblowers sue on the government’s behalf. The ruling vacated a 2024 trial-court decision that treated these citizens as improperly appointed federal officers. This matters because such cases can expose fraudulent billing or contracting when public agencies lack the information or capacity to act; successful whistleblowers may receive part of the recovery. The decision aligns the 11th Circuit with other federal appeals courts and protects an accountability route that has recovered billions of dollars. It does not decide whether the healthcare providers in the underlying Medicare case committed fraud, and defendants can pursue other arguments or further appeal. Financial rewards can also create incentives for weak claims, which is why judicial scrutiny remains essential. For workers who encounter suspected misuse of public money, the realistic step is not to confront an employer impulsively: preserve lawful records, note dates and reporting channels, and obtain independent legal advice about confidentiality, retaliation protection and filing deadlines. Sources: Reuters and the linked court order.
Texas tests whether data-centre electricity demand is real
What is materially new: Reuters reported on 1 September that Texas—the first major US data-centre hub to do so—has frozen new grid connections while regulators audit proposed projects, including their ultimate owners, incentives, water use and on-site generation. Across parts of the Midwest, Mid-Atlantic and South, large-user requests exceed 700 gigawatts, more than ten times estimated current US data-centre consumption. Many applications may duplicate projects or lack financing. Requiring deposits and study fees has already cut some utilities’ pipelines sharply: Exelon reduced its high-probability estimate by about 40%, while AEP Ohio’s fell by more than half. Better filtering could prevent households from paying for power plants and wires built for server campuses that never appear. The danger is the opposite error—discarding credible demand and leaving grids short—while inconsistent utility reporting makes comparisons uncertain. Residents may feel the consequences through bills, reliability, land and water use rather than through an AI service itself. Watch local utility dockets for named owners, financial guarantees and explicit rules separating data-centre costs from ordinary customers. Source: Reuters.
